Related Experiment Video

Updated: May 15, 2026

Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays
12:07

Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays

Published on: March 14, 2011

Short communication: nuclear JAK3 and its involvement in CD4 activation in HIV-infected patients

Ivan Landires1, Virginia Núñez-Samudio, Jacques Thèze

  • 1Unité d'Immunogénétique Cellulaire, Département Infection et Epidémiologie et Département d'Immunologie, Institut Pasteur, Paris, France. ivanlandires@yahoo.es

AIDS Research and Human Retroviruses
|January 10, 2013
PubMed

Insights

This study reveals Janus Kinase 3 (JAK3) in CD4 lymphocyte nuclei, with increased phosphorylated JAK3 (pJAK3) in HIV patients. This may drive immune activation and HLA-DR upregulation in HIV infection.

Area of Science:

  • Immunology
  • Cell Biology
  • Virology

Background:

  • Human Immunodeficiency Virus (HIV) infection is characterized by immune dysregulation.
  • The role of specific signaling molecules like Janus Kinase 3 (JAK3) in HIV-associated immune activation requires further elucidation.
  • Understanding subcellular localization of key proteins can provide insights into cellular function.

Purpose of the Study:

  • To investigate the subcellular localization of JAK3 in primary CD4 lymphocytes.
  • To compare JAK3 and phosphorylated JAK3 (pJAK3) levels in CD4 lymphocytes from healthy and HIV-infected individuals.
  • To explore the potential correlation between nuclear pJAK3 and immune activation markers in HIV.

Main Methods:

  • Quantitative image analysis was employed to determine the subcellular localization of JAK3.
  • Primary CD4 lymphocytes were isolated from both healthy donors and HIV-infected patients.
  • Levels of JAK3 and pJAK3 were quantified within the cellular compartments.

Main Results:

  • JAK3 was identified in the nuclei of primary CD4 lymphocytes, a novel finding.
  • Total JAK3 levels were comparable between healthy and HIV-infected donors.
  • Significantly higher levels of nuclear pJAK3 were observed in CD4 lymphocytes from HIV-infected patients compared to healthy controls.
  • A positive correlation was found between nuclear pJAK3 quantity and surface HLA-DR expression.

Conclusions:

  • The nucleus is a subcellular localization for JAK3 in CD4 lymphocytes.
  • Increased nuclear pJAK3 in HIV-infected individuals suggests a role in aberrant immune activation.
  • Nuclear pJAK3 may contribute to the increased HLA-DR expression observed in HIV infection, indicating a potential mechanism for immune dysregulation.

More Related Videos

Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.08:11

Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.

Published on: September 1, 2015

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...